Ascendis Pharma A Revenue per Employee (ASND), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Ascendis Pharma A  (NASDAQ: ASND)
 

Ascendis Pharma A's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 49.14% in the fourth quarter 2025, year on year to cumulative value of $814 million, Ascendis Pharma A's revenue per employee grew on a trailing twelve months basis to $ 8,141,969. The productivity of Ascendis Pharma A's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 11 other companies have achieved higher revenue per employee. While Ascendis Pharma A's total ranking has deteriorated compared to the previous quarter from 0 to 255. Ascendis Pharma A has 100 employees.


What is Sales per Employee Ratio?







ASND Revenue per Employee (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 49.14 % 292.89 % 362.52 % 2.14 % 26.24 %
Sales per Employee (TTM) $ 8,141,969 7,222,757 5,361,749 3,956,820 3,934,594
ASND's Total Ranking # 255 # 0 # # #
Seq. Revenue Change 11.76 % 39.27 % 68.6 % -43.17 % 194.42 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 12
Overall Market # 255

Revenue per Employee Statistics
High Average Low
$ 8,065,478 $ 1,877,814 $ 77,874
(Dec 31 2025)   (Dec 31 2020)



Financial Statements
Ascendis Pharma A's Revenue MRQ $ 279 Millions Visit ASND's Income Statement
Ascendis Pharma A's Revenues TTM $ 814 Millions Visit ASND's aggregate revenue growth
What are ASND's Sales? Visit ASND's Sales by Segment




Other Ratios
Ascendis Pharma A's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ASND's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ASND's Competitors
Revenue per Employee for ASND's Suppliers
Revenue per Employee for ASND's Customers

You may also want to know
ASND's Sales Growth Rates ASND's Pe Price to earnings ratio ASND's Receivables Turnover Ratio ASND's Stock Quote
ASND's Net Income Growth Rates ASND's Ps Price to Sales ratio ASND's Sales per Employee ASND's Asset Turnover Ratio
ASND's Net Margin ASND's Pb Price to Book ratio ASND's Financial Strength Ratios ASND's Dividend Payout Ratio
Date modified: 2026-09-18T14:10:37+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Atara Biotherapeutics Inc   8,668,214.29 $ 121.355  Million 14 
Ascendis Pharma A  8,065,478.40 $ 806.548  Million 100 
Inmode Ltd   7,561,122.45 $ 370.495  Million 49 
Argenx Se  7,316,520.91 $ 8,399.366  Million 1,148 
Agilon Health Inc   6,930,579.44 $ 5,932.576  Million 856 
Ligand Pharmaceuticals Incorporated  5,703,978.72 $ 268.087  Million 47 
Anika Therapeutics Inc   5,371,761.90 $ 112.807  Million 21 
P3 Health Partners Inc   4,559,625.00 $ 1,459.080  Million 320 
Xeris Biopharma Holdings Inc   4,489,923.08 $ 291.845  Million 65 
Novo Nordisk A  4,446,644.13 $ 309,064.000  Million 69,505 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.